Novolex announced today that Dennis Norman has been appointed Chief Financial Officer, effective March 1, 2021. In this capacity, Norman will lead Novolex’s finance organization and will be responsible for finance, accounting, treasury, risk management and information technology. He succeeds Paul Palmisano, who has elected to retire after providing exceptional financial guidance to Novolex for more than eight years.
“I am pleased to welcome Dennis to our leadership team,” said Novolex Chairman and CEO Stan Bikulege. “His proven track record of growth through both M&A and organic initiatives as well as his extensive experience in leading financial operations will make an immediate impact as we continue to position Novolex for the future. I am confident Dennis will provide strong leadership and prove an excellent addition to the Novolex team.”
Norman joins Novolex from nThrive, Inc., a healthcare IT and services company, where he contributed to significant transformation at the